FDA Approves Final Warning Language for Actos

Actos Lawyer

According to a Drug Safety Communication issued last week, the U.S. Food and Drug Administration announced it has approved the final language for the new Actos label. The drug’s label now includes warning language regarding the increased risk for bladder cancer in patients taking the medication for more than a year. The updated label also [...]

Use of Diabetes Drug Actos Linked to Increased Cancer Risk

actos

The Food and Drug Administration announced recently that prolonged use of Takeda Pharmaceutical’s diabetes drug, Actos (pioglitazone), may increase a patient’s risk for developing bladder cancer. The FDA also stated that product labeling would soon be updated to reflect the new information about the increased cancer risk. The warning was issued by the FDA following [...]